Characterization of ret oncogenic activation in MEN2 inherited cancer syndromes

Endocrinology

Volumn 137, Issue 5, 1996, Pages 1512-1519

  Xing, Shunhua ^a   Smanik, Patricia A ^a   Oglesbee, Michael J ^a   Trosko, James E ^b   Mazzaferri, Ernest L ^a   Jhiang, Sissy M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN; MUTANT PROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL COMMUNICATION; CELL STRAIN 3T3; CELLULAR DISTRIBUTION; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; NONHUMAN; NUDE MOUSE; ONCOGENE RET; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

EID: 0029935067     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.5.8612479     Document Type: Article

References (22)

1. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H 1988 Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3:571-578
2. Takahashi M, Buma Y, Hiai H 1989 Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. Oncogene 4:805-806
3. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M, Asai J 1995 Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene 10: 191-198
4. Schuchardt A, Srinivas S, Pachnis V, Costantini F 1995 Isolation and characterization of a chicken homolog of the c-ret proto-oncogene. Oncogene 10:641-649
5. Nakamura T, Ishizaka Y, Nagao M, Hara M, Ishikawa T 1994 Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J Pathol 172:255-260
6. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA 1993 Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2:851-856
7. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JBJ, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, Neumann HPH, Thibodeau SN, Ponder BAJ 1994 Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN2A and FMTC. Nature Genet 6:70-74
8. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA, Goodfellow PJ, Donis-keller H 1994 Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579-1583
9. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JWM, van Amstel HKP, Romeo G, Lips CJM, Buys CHCM 1994 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376
10. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GFW, Jackson CE, Tunnacliffe A, Ponder BAJ 1994 Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet 3:237-241
11. Ikeda I, Ishizaka Y, Tahira T, Suzuki T, Onda M, Sugimura T, Nagao M 1990 Specific expression of the ret proto-oncogene in human neuroblastoma cell lines. Oncogene 5:1291-1296
12. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Porta GD, Fusco A, Vecchio G 1990 PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557-563
13. Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti MA 1993 Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol Cell Biol 13:358-366
14. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460
15. Puchelle E, Gaillard D, Ploton D, Hinnrasky J, Fuchey C, Boutterin M, Jacquot J, Dreyer D, Pavirani A, Dalemans W 1992 Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium. Am J Respir Cell Mol Biol 7:485-491
16. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Di Fiore PP 1995 Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267:381-383
17. Loewenstein WR 1990 Cell-to-cell communication and the control of growth. Am Rev Respir Dis 142:s48-s53
18. Trosko JE, Mauhukar BV, Chang CC 1993 Endogenous and exogenous modulation of gap junctional intercellular communication: toxicological and pharmacological implications. Life Sci 53:1-19
19. Hotz-Wagenblatt A, Shalloway D 1993 Gap junctional communication and neoplastic transformation. Crit Rev Oncogen 4:541-558
20. Holder JW, Elmore E, Barrett JC 1993 Gap junction function and cancer. Cancer Res 53:3475-3485
21. El-fouly MH, Trosko JE, Chang C 1987 Scrape-loading and dye transfer, a rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 168:422-430
22. Asai N, Iwashita T, Matsuyama M, Takahashi M 1995 Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 15:1613-1619